Connecting Patients with Trials: A Transparent Approach to Recruitment
How does prioritising patient safety from project planning to trial conduct enhance clinical outcomes?
- On: August 21, 2024
Michael Busse
Head of Clinical Development & Operations Germany
How do you bridge the gap between feasibility studies and the reality of patient recruitment challenges?
To reflect patients’ needs and attempt to predict reality, we involve patients and patient organisations very early on — even prior to the protocol development. Besides patients, the participating sites are a major contributor to the success of a clinical trial. Their input is taken very seriously from the beginning, and we stay in close contact and support them throughout the conduct of the trial. In addition we plan patient centric recruitment support from the beginning on.
How do you ensure that patients are matched to the most suitable clinical trials?
We upload all suitable trials to an independent clinical trial patient platform. Trials of different sponsors are transparently listed there, and patients can easily search for the best-matching trial and an investigator close by. Patient can also contact the investigator directly via this platform.
How do you prioritise patient safety throughout the clinical development process?
Patient safety is of utmost importance. All suitable safety measures and safety reporting are always prioritised — from the very early project plans to the detailed trial protocols — and then implemented during the conduct of the trial. Safety reporting is made very easy for the site staff. Our inhouse pharmacovigilance colleagues continuously analyse the data. In most projects external data and safety monitoring boards evaluate the data on a continuous basis.
Learn more about patient recruitment as the crucial part of clinical trials with our esteemed speaker, Michael Busse, and his informative case study: “Patient Recruitment: How to Support Sites with Patient Centric Models?”
Join our 18th Annual Optimising Clinical Trials Summit: Site Selection, Feasibility and Patient Recruitment, 16 – 17 October 2024, Mercure Hotel MOA Berlin!
Short Speaker BIO:
Michael Busse, Head of Clinical Development & Operations Germany at Boehringer Ingelheim is a physician by training, specialised in general medicine. Michael holds a master in pharmaceutical medicine and worked in different local & global, strategic & operational roles including Medical Affairs, Clinical Development and Clinical Operations. He is passionate about early partnerships with healthcare professionals and patient representatives to ensure patient- and site-centric clinical trials. Michael has a special interest and experience in leadership, innovative projects, change management and cross functional work. Apart from work, he enjoys travelling with his family to discover new countries and learn from different cultures.
You might also like
